AMT Medical
Life Sciences & Health
The level of care in the Netherlands is high, but costs are rising and care is not equally accessible to everyone. We need to take action now, otherwise healthcare costs will become unaffordable and in the future, one in four Dutch people will have to work in healthcare to maintain the current level. With dedication, we are committed to a affordable, manageable, and accessible healthcare system.
We focus on innovative enterprises and initiatives that are committed to preventing, replacing, and relocating costly healthcare. We develop models that make preventive care financeable and invest in the diagnostics and medical technology of tomorrow. In this way, we work on various fronts to achieve a sustainable transition of the sector.
Our strategic choices
Everything for us revolves around making healthcare future-proof. We mainly focus on digital health, personalized diagnostics, preventive healthcare, and medical technology. We do this with capital, but also by developing financial instruments. Additionally, we invest in scaling impactful, local initiatives that intelligently combine healthcare domains. And because measurement is knowledge, we take a leading role in quantifying the impact of healthcare innovations.
Life Sciences & Health portfolio
We are proud of the companies we invest in and the funds we participate in. With these entrepreneurs and partners, we make an impact.
What do we focus on
To change healthcare, we promote initiatives that contribute to innovation in the sector. Think of robotics and AI, but also prevention and an impact model for healthcare innovations.
Focus area 1
MedTech
Technology can ease the burden on the sector and patients. We are investing in solutions that minimize invasive surgery, and in robotics that can automate tasks and accelerate processes.
Focus area 2
Digital Health
Artificial Intelligence is taking off rapidly, also in healthcare. AI is excellent for automatic diagnostics, treatment planning, telemedicine, and ICT support in healthcare.
Focus Area 3
Therapeutics
Invest-NL strategically invests in medicines that are in Phase I or later. The condition is that these improve the quality of care, make treatments more accessible, and reduce treatment costs.
Focus area 4
Funding prevention
More focus on promoting health prevents complaints and thus rising healthcare costs. That is why we are working on results-based financing as an alternative funding model for prevention and cross-sectoral care.
Focus Area 5
Measuring impact
Investors seek guidance. That's why we are developing an impact model for healthcare innovations, with standardized impact dimensions and calculation methodology. This makes evaluating impact easier and encourages funding for promising healthcare ventures.
Our experts in Life Sciences & Health
To all colleagues
Our publications
We don't just offer capital, but also expertise. With our legal, financial, and technical know-how, we resolve issues and provide important sectors with prospects. We are happy to share our insights!
With a few brief, targeted questions, we assess whether your project or company qualifies for funding.
Questions about this topic? Stanley is happy to help!
Stanleyson Hato
team lead Life Sciences & Health
View all our themes
We want to make an impact. We do this within a number of strategic themes: Agrifood, Biobased & Circular Economy, Deep Tech, Energy, and Life Sciences & Health. See how we are taking steps together within these themes.
The Netherlands is aiming for a sustainable and climate-neutral food system. This requires a shift towards the production and consumption of mainly plant-based proteins, and a transition to regenerative agriculture. We invest in companies and encourage sectors related to plant-based proteins, soil quality restoration, biodiversity, and regenerative farming.
The Netherlands has set itself the goal of becoming a fully circular and bio-based economy by 2050. We focus on preventing overconsumption and waste and on restoring natural ecosystems. We work together on new financing solutions and invest in companies that contribute to a successful circular economy.
Our National Technology Strategy identifies ten technologies that are vital for our economic growth, national security, and solving societal challenges. To succeed in this, significant investments are needed to help deep tech companies overcome the notorious 'valley of death'. That is the role of our Deep Tech Fund.
To limit climate change, a radical shift from fossil fuels to sustainable technologies and energy sources is necessary. We aim for a fully CO₂-neutral and circular energy system by 2050. We are working on scaling up alternatives to fossil fuels, strengthening the economic structure through innovation, and promoting energy saving.